Go Deep
Bone Biologics Corporation
Bone Biologics Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,136 | -0.3 | 0.27 | 0.00 | 36.71 |
| Oct 2026 | 23,120 | -0.3 | 0.28 | 0.00 | 37.41 |
| Oct 2026 | 21,267 | -0.3 | 0.29 | 0.00 | 38.92 |
| Oct 2026 | 21,190 | -0.3 | 0.30 | 0.00 | 40.77 |
| Oct 2026 | 21,212 | -0.3 | 0.29 | 0.00 | 39.72 |
| Oct 2026 | 21,210 | -0.3 | 0.28 | 0.00 | 38.28 |
Bone Biologics Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -773,702.0 | -765,988.0 | -684,643.0 | -666,737.0 |
| EPS | -0.4 | -0.4 | — | -0.4 |
Bone Biologics Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -3,108,991.0 | -4,112,420.0 | -8,948,731.0 | -1,484,620.0 | — |
| EPS | -2.6 | -29.0 | -204.1 | -186.9 | — |
Bone Biologics Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 5,796,135.0 | 3,861,369.0 | 3,737,763.0 | 8,495,237.0 | — |
| Total Liabilities | 418,587.0 | 377,712.0 | 831,402.0 | 2,547,929.0 | — |
| Total Equity | 5,377,548.0 | 3,483,657.0 | 2,906,361.0 | 5,947,308.0 | — |
Owes vs Owns
Bone Biologics Corporation owed $0.12 for every $1 it owned in Jun 2026, down from $0.30 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.12× | 0.07× | 0.10× | 0.22× | 0.30× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bone Biologics Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 92.0%Other assets 7.8%
How it's funded — Dec 2025
Payables 7.2%Shareholders' equity 92.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 5.3 | 3.3 | 3.0 | 7.5 |
| Receivables | 0.0 | 0.0 | 0.3 | 0.6 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.5 | 0.5 | 0.4 | 0.4 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 0.4 | 0.4 | 0.4 | 0.1 |
| Other liabilities | 0.0 | 0.0 | 0.5 | 2.4 |
| Shareholders' equity | 5.4 | 3.5 | 2.9 | 5.9 |
| Net tangible assets | 5.4 | 3.5 | 2.9 | 5.9 |
Bone Biologics Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -2,691,150.0 | -4,124,935.0 | -9,555,904.0 | -3,566,913.0 | — |
| Financing Activities | 4,700,341.0 | 4,423,497.0 | 5,044,161.0 | 4,429,860.0 | — |